Hydroxyurea (HU) has been used in cancer chemotherapy for many years. It has been of manifold pharmacological interest, so it has been used for the treatment of melanoma, chronic myelocytic leukemia, and recurrent, metastatic, or inoperable ovarian cancer. HU is also used in therapy of squamous cell carcinomas in the head and neck and relapsed metastasis ovarian cancer, 1) and people have found that it has certain effect on sickle cell anemia, 2) beta-thalassemia, 3) and psoriasis.
Hydroxyurea (HU) has been used in cancer chemotherapy for many years. It has been of manifold pharmacological interest, so it has been used for the treatment of melanoma, chronic myelocytic leukemia, and recurrent, metastatic, or inoperable ovarian cancer. HU is also used in therapy of squamous cell carcinomas in the head and neck and relapsed metastasis ovarian cancer, 1) and people have found that it has certain effect on sickle cell anemia, 2) beta-thalassemia, 3) and psoriasis. 4) It is also reported that HU has been used for the treatment of AIDS in combination with didanosine, showing no viral rebound after one year treatment. 5) HU causes an immediate inhibition of DNA synthesis by acting on the R 2 subunit of the ribonucleotide reductase. [6] [7] [8] Therapeutic application of HU has several disadvantages such as short half-life (1.9-3.9 h) in patients due to its small molecular size (MWϭ76.06) and extremely polar nature (Clog P o/w ϭ Ϫ1.80), the necessity of using a high dosage (80 mg/kg every third day or 20-30 mg/kg daily), and the rapid development of resistance. 1, [9] [10] [11] In this study, structure modification of HU based on increasing its hydrophobic nature and molecular size has been adopted to obtain a more potent compound. A series of monosubstituents and disubstituents of HU with different benzyls were synthesized and their structures were elucidated using spectrometry along with X-ray crystal structures analysis for representative compounds. The antitumor activity tests in vitro for human tongue cancer cell line and murine leukemia cell line were evaluated.
Results and Discussion
Synthesis The target compounds were prepared using the reaction sequence in Chart 1. The compounds 2a-f were synthesized in good yield by condensation of HU with various benzyls (1a-f) in the presence of potassium hydroxide under reflux. The condensation of 2a-f with HU afforded compounds 3a-f. The chemical structures of the synthesized compounds (2a-f and 3a-f) were confirmed by spectroscopic methods, and exact stereostructures of compounds 2a and 3f have been determined by X-ray crystal structure analysis.
X-Ray Crystal Structure Analysis The crystallographic data of 2a are summarized in Table 1 . The selected bond lengths, angles and torsion angles are given in Table 2 . ORTEP drawings of the compounds 2a and 3f 12) are illustrated in Fig. 1 . Crystallographic data and the structure analysis of compound 3f have been outlined in the previous paper. 12) Conformations of the C8ϭO2 double bond and N1-O1 bond in 2a are the opposite of each other, similar to that observed in 3f (C1ϭO2 double bond and N1-O1 bond), N-hydroxyurea [13] [14] [15] [16] [17] and other hydroxyurea derivates.
18) The length of the carbonyl bond (C8ϭO2) in 2a is in the normal range of 1.19-1.23 Å, similar to that observed in 3f, 12) but obviously shorter than N-hydroxyurea, 1-hydroxy-1-methylurea and 1-hydroxy-3-methylurea (Ͼ1.25 Å). This may be related to the hydroxyl etherification. The average distance between the carbon atom and the coordination nitrogen atom is 1.300 (3) Å. The group N-(CϭO)-N urea planar forms a dihedral angle of 71.48 (15) °with the benzyl group, and the N-O bonds are twisted by about 20°out of the N-(CϭO)-N urea planes. In the crystal structure, molecules are linked to antiparallel chains running along the b axis by intermolecular N-H … O hydrogen bonding (Fig. 2) . The hydrogen bonding parameters are summarized in Table 3 .
Antitumor Evaluation The prepared compounds were evaluated for their cytotoxicity against cancer in vitro using HU as positive control. Firstly, compounds 2a-d and 3a-d were evaluated for their cytotoxic activity in vitro against human tongue cancer cell line (Tca8113). The results are summarized in Table 4 . As shown in Table 4 , compounds 3a, 3b and 3d are the most active compounds to Tca8113 cells with IC 50 values ranging from 5.29ϫ10 Ϫ4 ϫ2.87 mM, with 3d exhibiting the most potent activity (IC 50 is 5.29ϫ10 Ϫ4 mM). Because of the good results, we continued to synthesize the hydroxyurea derivatives 2e-f and 3e-f, and evaluated the cytotoxicity by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for all the target products using murine leukemia cell line L1210. The ranking order of the cytotoxicity of all the compounds is 3eϾ3d
Ͼ3aϾ3dϾ2dϾ3dϾ3cϾ3dϾ3bϾ3dϾ3fϾ3dϾ2eϾ3dϾHU
Ͼ3dϾ2aϾ3dϾ2cϾ3dϾ2bϾ3dϾ2f. Among them, the most promising compounds were 3e, 3d, 3a and 2d. The IC 50 ratios of HU over compounds 3e, 3d, 3a and 2d range from 10 to 40, indicating that the four compounds are 10 to 40 fold more potent than HU against L1210 cells. 3c, 3b and 3f also had remarkable activity.
The approximate partition coefficient Clog P of each de- Table 2 . Selected Bond Distances (Å), Angles (°), and Torsion Angles (°) for 2a Table 3 . Hydrogen Bonding Geometry (Å,°) of 2a rivative compound was calculated, and the values are included in Table 4 . The higher Clog P value corresponds to the stronger hydrophobic or weaker hydrophilic nature of the compound. After the chemical modification, all of the HU derivatives possessed higher Clog P values than HU. Notably, disubstituents 3 with higher Clog P showed higher cytotoxity than the corresponding monosubstituents 2 with lower Clog P, suggesting that the stronger hydrophobic nature of the HU derivatives might favor the cytotoxic activity.
In conclusion, the desired HU derivatives were prepared. From the data of antitumor activity tests in vitro, some of them showed high or medium cytotoxicity against the cancer cell lines Tca8113 and L1210. Among them, the most promising compounds were 3e, 3d, 3a and 2d. To assess the potentials of these new compounds as cancer chemotherapeutic agents, further in vivo activity and toxicity studies are needed. The results obtained from this study can be used as guidelines for further development.
Experimental
Materials The starting compounds (1a-f) were purchased from Shanghai Darei Finechemical Co., Ltd., China. Hydroxyurea was purchased from Lingyi Furei Finechemical Co., Ltd., China. All reagents were obtained from commercial sources and used without further purification unless stated. Methanol was dried over calcium chloride and distilled. Acetone was dried over magnesium sulphate and distilled.
Apparatus Melting points (mp) were determined using a capillary method and were uncorrected. IR spectra were recorded on a Shimadzu FT-IR 8400 spectrometer (KBr pellets). 1 H-and 13 C-NMR spectra were recorded on a Bruker AV 400 MHz spectrometer. Mass spectra were recorded on a Waters 2695 LC-ZQ4000 system. Crystal data were collected by a Bruker APEX-II area-detector diffractometer.
Cell Lines The human tongue cancer cell line Tca8113 was provided by the Institute of Medical Sciences in Jiangxi province, China and the lymphocytic murine leukemia cell line L1210 was purchased from Nanjing Keygen Biotech. Co., Ltd., China. The two cell lines were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 IU/ml penicillin G and 100 IU/ml streptomycin sulfate at 37°C in a humidified atmosphere containing 5% CO 2 atmosphere.
Production of 2a-f. General Procedure Potassium hydroxide (34 mmol) and benzyl chloride or benzyl bromide with different substituents on phenyl (1a-f) (26 mmol) were added to a solution of hydroxyurea (26 mmol) in methanol (80 ml). The reaction mixture was refluxed and checked by TLC until HU was consumed; solvent was removed under reduced pressure at 35°C. The resulting crude solid was filtered and washed in chloroform, then recrystallized in acetone and chloroform (5 : 2) to get 2a-f as colorless crystals. Production of 3a-f. General Procedure Potassium hydroxide (17 mmol) and benzyl chloride or benzyl bromide with different substituents on phenyl (1a-f) (13 mmol) were added to a solution of compounds 2a-f (13 mmol) in methanol (80 ml). After refluxing for 14-18 h (as evidenced by TLC), solvent was removed under reduced pressure at 35°C. The residue was extracted with ether and the extraction solution was concentrated under reduced pressure. The crude product was column chromatographed on silica using acetone/chloroform (1 : 4) as eluent, solvent was eliminated from the elution under reduced pressure and then recrystallized in an acetone and chloroform mixture (5 : 1.5) to get 3a-f as colorless crystals.
1-Benzyl-1-benzyloxyurea (3a): Yield 32%. mp 97-98°C. X-Ray Crystallography Colorless needle-shaped single crystals of the compound 2a suitable for X-ray structure analysis were obtained by slow evaporation from the mixed solvent acetone and N-hexane (9 : 11) at room temperature for one week. The X-ray data were collected on a diffractometer equipped with graphite-monochromated MoKa radiation (lϭ0.71073 Å) at 296(2) K. The structure was determined by direct methods and refined on F 2 by full-matrix least-squares using the program SHELXTL-97. 19 ) An X-ray diffraction study of the compound showed that it was crystallized in a monoclinic system with the P2 1 /c space group. Non-hydrogen atoms were refined with anisotropic displacement parameters. H atoms were calculated and allowed to ride. Computer programs: structure solution, SHELXS-97, 19) refinement, SHELXS-97, 20) molecular diagrams, ORTEP.
21)
Pharmacology The newly synthesized compounds were evaluated for their in vitro cytotoxicity by growth-inhibition studies using two cancer-cell lines: human tongue cancer cell line (Tca8113) and murine leukemia cell line (L1210). Sulforhodamine B (SRB) assay 22) was used for study of Tca8113 cells, while MTT assay 23) was used of L1210 cells. SRB Method Tumor cells (1ϫ10 5 cells ml Ϫ1 ) were inoculated in 96-well culture plates (100 ml/well). After culture for 24 h at 37°C in a 5% CO 2 atmosphere, 50 ml of culture medium containing synthetic compound of various concentrations was added to the wells, the cells were then incubated for 65 h, and the medium was removed by suction. The cells were fixed with 10% cold trichloroacetic acid (TCA) and the plates were kept at 4°C for 1 h. The TCA was removed by suction, and the plates were rinsed with water repeatedly 5 times and stained with SRB 0.4% (w/v) in 1% acetic acid for 15 min. Excess dye was washed out by 1% acetic acid repeatedly 5 times, air dried and the bound stain was subsequently solubilized with 150 ml Tris base (tris(hydroxy-methyl)aminomethane). The absorbance of SRB solution was measured at 490 nm with a microplate reader.
MTT Method Tumor cells (1ϫ10 6 cells ml
Ϫ1
) were inoculated in 96-well culture plates (100 ml/well). After cultured for 24 h, 50 ml of culture medium containing synthetic compound of various concentrations was added to the wells, then the cells were incubated for 65 h. Twenty microliters of MTT was added at a final concentration of 5 mg/ml and after 4 h incubation, 150 ml of DMSO was added and the optical density was measured at 490 nm.
